BackRhelion Life Sciences Overview
Rhelion Life Sciences Corp.

Rhelion Life Sciences Return on Equity

Valuation check: TRUFF's ROE is -34.92%, below the sector sector average of 10.27%.

Get informed when a big investor buys or sells

+ Follow

ROE

-34.92%

Return on Equity

-34.92%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Rhelion Life Sciences (TRUFF) FAQ

Rhelion Life Sciences (TRUFF) currently reports a ROE of -34.92%. That is below the sector sector average of 10.27%. Use the charts on this page to explore Rhelion Life Sciences's ROE history and peer comparisons.

Rhelion Life Sciences's ROE of -34.92% is lower than the its sector sector average of 10.27%. That is roughly 440.2% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' ROE, but Rhelion Life Sciences's current -34.92% should be judged against industry norms (sector average: 10.27%) and against TRUFF's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current ROE of -34.92%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 10.27%. From there, open related valuation or income-statement pages for Rhelion Life Sciences, and consider following TRUFF for alerts when major investors trade the stock.

Questions & Answers